Skin Benefits and Downsides of GLP-1 Treatment: Better Patient Reports of Inflammatory Skin Conditions During the 'Ozempic Face' Trend

Patient-reported changes in skin, hair, and nails were identified in individuals using glucagon-like peptide 1-receptor agonists (GLP-1RAs) for weight management.

• Facial hollowing, sinking cheeks, and skin laxity, collectively referred to as 'Ozempic Face,' have garnered attention as potential dermatologic effects.
• There is a need for patient-reported data to better characterize these dermatologic effects associated with GLP-1RAs.
• The study aims to correlate the frequency of reported dermatologic effects with the extent of weight loss experienced by patients.

Simplified